Antiviral Activity of Recombinant Rat Interferon Gamma in Immunologically Impaired and Immunosuppressed Rats

References

1. ANDERSON R. E., WARNER N. L. 1976; Ionizing radiation and the immune response. Advances in Immunology 24:215–335
   [Google Scholar]
2. BENACERRAF B., KIVY-ROSENBERG E., SEBESTYEN M. M., ZWEIFACH B. W. 1959; The effect of high dose X-irradiation on the phagocytic, proliferative and metabolic properties of the reticuloendothelial system. Journal of Experimental Medicine 110:49–63
   [Google Scholar]
3. BOLHUIS R. L. H., SCHELLEKENS H., DE REUS A., WEIMAR W., CANTELL K. 1981 Host-mediated antiviral effect by interferon in vivo. The Biology of the Interferon System125–129 Edited by De Maeyer E., Galasso G., Schellekens H. Amsterdam: Elsevier/North-Holland;
   [Google Scholar]
4. BRANCA A. A., BAGLIONI C. 1981; Evidence that type I and type II interferons have different receptors. Nature, London 294:768–770
   [Google Scholar]
5. BROERSE J. J., ZOETELIEF J. 1984 The occurrence of radiation syndromes in rodents and monkeys in dependence of dose rate and radiation quality. Response of Different Species to Total Body Irradiation175–187 Edited by Boerse J. J., MacVittie T. J. The Hague: Martinus Nijhoff;
   [Google Scholar]
6. CATANZARO P. J., SCHWARTZ H. J., GRAHAM R. C. 1971; Spectrum and possible mechanism of carrageenan cytotoxicity. American Journal of Pathology 64:387–404
   [Google Scholar]
7. CRUZ J. R., DAMMIN G. J., WANER J. L. 1981; Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection. Infection and Immunity 32:332–342
   [Google Scholar]
8. CZARNIECKI C. W., FENNIE C. W., POWERS D. B., ESTELL D. A. 1984; Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta and gamma interferons. Journal of Virology 49:490–496
   [Google Scholar]
9. DIJKEMA R., VAN DER MEIDE P. H., POWELLS P. H., CASPERS M., DUBBELD M., SCHELLEKENS H. 1985; Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO Journal 4:761–767
   [Google Scholar]
10. DURUM S. K., GENGOZIAN N. 1978; The comparative radiosensitivity of T and B lymphocytes. International Journal of Radiation Biology 34:1–15
    [Google Scholar]
11. FRASER G., RAMACHANDRAN S. P. 1969; Studies on the virus of Aujeszky’s disease. I. Pathogenicity for rats and mice. Journal of Comparative Pathology 79:435–444
    [Google Scholar]
12. GRESSER I., TOVEY M. G., BOURALI-MAURY C. 1975; Efficacy of exogenous interferon treatment after onset of multiplication of vesicular stomatitis virus in the brains of mice. Journal of General Virology 27:395–398
    [Google Scholar]
13. KAPLAN E. L., MEIER P. 1958; Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53:457–481
    [Google Scholar]
14. KIESSLING R., KLEIN E., PROSS H., WIGZELL H. 1975; Natural killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. European Journal of Immunology 5:117–121
    [Google Scholar]
15. MAES R. K., KANITZ C L., GUSTAFSON D. P. 1979; Pseudorabies virus infections in wild and laboratory rats. American Journal of Veterinary Research 40:393–396
    [Google Scholar]
16. MORRIS A. G., YUN-LU L., ASKONAS B. A. 1982; Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature, London 295:150–152
    [Google Scholar]
17. NARA P. L. 1982 Porcine herpesvirus 1. Comparative Pathobiology of Viral Diseases 190–113 Edited by Olsen J. R., Krakowka S., Blakeslee J. R. JR Boca Raton: CRC Press;
    [Google Scholar]
18. O’MALLEY I. A., NUSSBAUM-BLUMENSON A., SHEEDY D., GROSSMAYER B. J., OZER H. 1982; Identification of the T cell subset that produces human γ interferon. Journal of Immunology 128:2522–2526
    [Google Scholar]
19. PETO R., PIKE M. C, ARMITAGE P., BRESLOW N. E., COX D. R., HOWARD S. V., MANTEL N., MCPHERSON K., PETO J., SMITH P. G. 1976; Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. British Journal of Cancer 34:585–612
    [Google Scholar]
20. PETO R., PIKE M. C, ARMITAGE P., BRESLOW N. E., COX D. R., HOWARD S. V., MANTEL N., MCPHERSON K., PETO J., SMITH P. G. 1977; Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 35:1–39
    [Google Scholar]
21. ROSA F., FELLOUS M. 1984; The effect of gamma-interferon on MHC antigens. Immunology Today 5:261–262
    [Google Scholar]
22. SCHELLEKENS H., WEIMAR W., CANTELL K., STITZ L. 1979; Antiviral effect of interferon in vivo may be mediated by the host. Nature, London 278:742
    [Google Scholar]
23. SCHELLEKENS H., WEIMAR W., DE REUS A., BOLHUIS R. L. H., CANTELL K. 1981; In vivo immune stimulation by interferon during viral infection. Antiviral Research 1:179–183
    [Google Scholar]
24. SCHELLEKENS H., SMIERS-DE VREEDE A., DE REUS A., DIJKEMA R. 1984; Antiviral activity of interferon in rats and the effect of immune suppression. Journal of General Virology 65:391–396
    [Google Scholar]
25. SHALABY M. R., SVEDERSKY L. P., MCKAY P. A., FINKLE B. S., PALLADINO M. A. JR 1985; In vivo augumentation of natural killer activity by combined treatment with recombinant gamma interferon and interleukin-2. Journal of Interferon Research 5:571–581
    [Google Scholar]
26. SIBBITT W. L., IMIR T., BANKHURST A. D. 1986; Inert particles inhibit natural killer cell function in vitro. Cellular Immunology 97:146–154
    [Google Scholar]
27. SIDMAN C. L., MARSHALL J. D., SHULTZ L. D., GRAY P. W., JOHNSON H. M. 1984; y-interferon is one of several direct B cell-maturing lymphokines. Nature, London 309:801–803
    [Google Scholar]
28. STEEG P. S., MOORE R. N., JOHNSON H. M., OPPENHEIM J. J. 1982; Regulation of murine macrophage la antigen expression by a lymphokine with immune interferon activity. Journal of Experimental Medicine 156:1780–1793
    [Google Scholar]
29. TALIAFERRO W. H., TALIAFERRO L. G., JAROSLOW B. N. 1964 Radiation and Immune Mechanisms83–107 New York: Academic Press;
    [Google Scholar]
30. TRINCHIERI G., PERUSSIA B. 1985; Immune interferon: a pleiotropic lymphokine with multiple effects. Immunology Today 6:131–136
    [Google Scholar]
31. VAN DER MEIDE P. H., DUBBELD M., VIJVERBERG K., KOS T., SCHELLEKENS H. 1986; The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. Journal of General Virology 67:1059–1071
    [Google Scholar]
32. VRIESENDORP H. H., VAN BEKKUM D. W. 1980 Role of total body irradiation in conditioning for bone marrow transplantation. Immunology of Bone Marrow Transplantation349 Wien & New York: Springer-Verlag;
    [Google Scholar]
33. WIRTH J. J., CARNEY W. P., WHEELOCK E. F. 1980; The effect of particle size on the immunodepressive properties of silica. Journal of Immunological Methods 32:357–373
    [Google Scholar]